Hyphens Pharma International Ltd. Email Format
Pharmaceutical ManufacturingCentral Region, Singapore201-500 Employees
Hyphens Pharma International Ltd., based in Singapore, operates as a pharmaceutical manufacturer and distributor and is listed on the Catalist board of the Singapore Exchange. The group maintains its headquarters in Singapore and has a regional presence across Vietnam, Malaysia, Indonesia, and the Philippines, with a broader marketing and distribution network extending to 14 additional markets in Asia and the Gulf region. It comprises five entities—Hyphens Pharma, DocMed Technology, Ocean Health, Novem, and Ardence Pharma—with core activities in specialty pharma principals, proprietary brands, and a medical hypermart and digital platform. The company uses exclusive distributorships and licensing with global principals to bring specialty pharmaceutical products to selected ASEAN markets, while also developing, marketing, and selling proprietary dermatological and health supplement brands regionally. It operates a medical hypermart that supplies healthcare professionals, institutions, and retail pharmacies with essential pharmaceutical products and medical supplies. A notable development in January 2026 is the European launch of Cerapro MED Skin Barrier Cream through a partnership with Louis Widmer SA, expanding into six European markets.